Comparison of real-world outcomes following immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma with outcomes of randomized controlled trials.
Anirudh YalamanchaliKailin YangLogan RoofNerea Lopetegui-LiaLarisa M SchwartzmanShauna R CampbellNeil McIver WoodyNatalie SilverShlomo KoyfmanJessica L GeigerEmrullah YilmazPublished in: Head & neck (2023)
Real-world outcomes of IO in R/M HNSCC are similar to outcomes in randomized control trials, with performance status and ALC correlating with OS.